
About HP Pharmaceuticals Private Limited
Data last updated:
HP Pharmaceuticals Private Limited is a private limited company based in Saptapur, Karnataka, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 30 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51109KA2015PTC084983. Its GSTIN is 29AADCH8143D1ZM (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Amrutha Deepak Havanur and Anasuya Shivanand Havanur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 01 First Floor Sharada School Road Michigan Compound, Saptapur, Karnataka, India – 580001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.21 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹5.63 Lakh (net margin 4.7%) and EBITDA of ₹7.65 Lakh (EBITDA margin 6.3%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hpparmaceuticals.com.
Company details
Contact details
HP Pharmaceuticals Private Limited's registered office is in Saptapur, Karnataka. Its website is hpparmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo. 01 First Floor Sharada School Road Michigan Compound, Saptapur, Karnataka, India – 580001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of HP Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of HP Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of HP Pharmaceuticals Private Limited, buy the company report.
Financials of HP Pharmaceuticals Private Limited
FY 2025 filings availableHP Pharmaceuticals Private Limited reported revenue of ₹1.21 Cr (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 1% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.65 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.63 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.3% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of HP Pharmaceuticals Private Limited, buy the company report.
Board of directors of HP Pharmaceuticals Private Limited
HP Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amrutha Deepak Havanur | Director | 29 Mar 2021 | 5 Years 7 Months | Current |
| Anasuya Shivanand Havanur | Director | 29 Mar 2021 | 5 Years 7 Months | Current |
Peer comparison
HP Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Milus Pharmaceuticals Private Limited | ₹1.21 Cr (FY 2024) | 228.0% | Mumbai, Maharashtra, India | |||
| Herumb Pharmaceuticals and Chemical Private Limited | ₹1.21 Cr (FY 2024) | 1886.0% | Rajkot, Gujarat, India | |||
| Nordic Pharmaceuticals Limited | ₹1.21 Cr (FY 2025) | -10.0% | New Delhi, Delhi, India | |||
| Levitas Pharmaceuticals Private Limited | ₹1.21 Cr (FY 2018) | 14.0% | Ernakulam, Kerala, India | |||
| HP Pharmaceuticals Private Limitedthis company | ₹1.21 Cr (FY 2025) | ₹5.63 Lakh | 4.7% | 1.0% | Saptapur, Karnataka, India | |
| Toran Pharmaceuticals Private Limited | ₹1.2 Cr (FY 2025) | 35.0% | Kashipur, Uttarakhand, India | |||
| E M Pharmaceuticals Private Limited | ₹1.2 Cr (FY 2025) | -6.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of HP Pharmaceuticals Private Limited, buy the company report.
Auditor
HP Pharmaceuticals Private Limited is audited by MURALIDHARAN AND MANOGARAN for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MURALIDHARAN AND MANOGARAN | FY 2017 | 008413S |
Shareholding
The shareholding of HP Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of HP Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving HP Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for HP Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
HP Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCH8143D1ZM | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of HP Pharmaceuticals Private Limited, buy the company report.
Recent activity
HP Pharmaceuticals Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Bindu ceased to be Director on 05 Oct 2021.
Frequently asked questions
HP Pharmaceuticals is an active private limited company based in Saptapur, Karnataka, India. The company works in other wholesale, within the trading industry. It was incorporated on 30 December 2015 (11+ years old) and is registered under CIN U51109KA2015PTC084983.
HP Pharmaceuticals has 2 current directors:
- Amrutha Deepak Havanur - Director
- Anasuya Shivanand Havanur - Director
The latest financial statements of HP Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of HP Pharmaceuticals is 29AADCH8143D1ZM, registered in Karnataka.
The CIN (Corporate Identification Number) of HP Pharmaceuticals is U51109KA2015PTC084983. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
HP Pharmaceuticals was incorporated on 30 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of HP Pharmaceuticals by revenue are Milus Pharmaceuticals Private Limited, Herumb Pharmaceuticals and Chemical Private Limited, Nordic Pharmaceuticals Limited, Levitas Pharmaceuticals Private Limited, Toran Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Bindu ceased to be Director on 05 Oct 2021. Shashank Shivakumar Bagalkot ceased to be Director on 05 Oct 2021. Amrutha Deepak Havanur was appointed as Director on 29 Mar 2021. HP Pharmaceuticals has 4 board changes on record in total.
HP Pharmaceuticals can be reached through the website hpparmaceuticals.com. Its registered office is in Saptapur, Karnataka, India.
The registered office of HP Pharmaceuticals is at No. 01 First Floor Sharada School Road Michigan Compound, Saptapur, Karnataka, India – 580001.
HP Pharmaceuticals operates in the trading industry, in the other wholesale segment.

